ID: ALA4583619

Max Phase: Preclinical

Molecular Formula: C31H44O4

Molecular Weight: 480.69

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CCc5c(cc(OC)c(O)c5C)[C@]4(C)CC[C@@]3(C)[C@@H]2C1

Standard InChI:  InChI=1S/C31H44O4/c1-19-20-9-10-23-29(4,21(20)17-22(34-7)25(19)32)14-16-31(6)24-18-28(3,26(33)35-8)12-11-27(24,2)13-15-30(23,31)5/h10,17,24,32H,9,11-16,18H2,1-8H3/t24-,27-,28-,29+,30-,31+/m1/s1

Standard InChI Key:  SMKTVMGGXSRBQK-ZRCCSVPJSA-N

Associated Targets(Human)

Nuclear receptor subfamily 4 group A member 1 458 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HepG2 196354 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 480.69Molecular Weight (Monoisotopic): 480.3240AlogP: 7.04#Rotatable Bonds: 2
Polar Surface Area: 55.76Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 10.25CX Basic pKa: CX LogP: 7.20CX LogD: 7.19
Aromatic Rings: 1Heavy Atoms: 35QED Weighted: 0.36Np Likeness Score: 2.59

References

1. Chen Z, Zhang D, Yan S, Hu C, Huang Z, Li Z, Peng S, Li X, Zhu Y, Yu H, Lian B, Kang Q, Li M, Zeng Z, Zhang XK, Su Y..  (2019)  SAR study of celastrol analogs targeting Nur77-mediated inflammatory pathway.,  177  [PMID:31132532] [10.1016/j.ejmech.2019.05.009]

Source